Amino-acid PET imaging is an efficient complementary tool to MRI for the assessment of
gliomas, principally for high-grade gliomas [1] and is now recommended by the Response …

PET using radiolabelled amino acids is a rapidly evolving method that can significantly
enhance the diagnostic value of MRI in brain tumours. Current developments suggest that …

PET with amino acid tracers provides additional insight beyond MR imaging into the biology
of gliomas that can be used for initial diagnosis, delineation of tumor margins, planning of …

Positron emission tomography (PET) is a nuclear medicine imaging method with increasing
relevance for the diagnosis, prognostication, and monitoring of glioblastomas. PET provides …

The Response Assessment in Neuro-Oncology Working Group has analysed the role of
clinically established PET methods in the diagnostic assessment of brain tumours. The …

For the primary diagnosis of brain tumours, morphological imaging by means of magnetic
resonance imaging (MRI) is the current method of choice. The complementary use of …

Positron emission tomography (PET) using radiolabeled amino-acids was recently
recommended by the Response Assessment in Neuro-Oncology (RANO) working group as …

Background Static imaging of amino acids does not allow differentiation of low versus high
grade brain tumours. It has been shown that dynamic imaging of the amino acid analogue …

For decades, several amino acid PET tracers have been used to optimize diagnostics in
patients with brain tumors. In clinical routine, the most important clinical indications for amino …

For more than three decades, radiolabeled amino acids have been used in the field of neuro-
oncology. The most experience for this class of positron emission tomography (PET) tracers …